Related Experiment Video
Updated: Apr 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era
Annelot F Schoffelen1, Colette Smit2, Steven F L van Lelyveld3
1Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht.
Insights
In HIV-infected individuals, being of Sub-Saharan African origin was linked to higher initial chronic kidney disease (CKD) rates. However, ethnicity did not affect the risk of developing new CKD over time, suggesting changing causes.
Area of Science:
- Nephrology
- Infectious Diseases
- Epidemiology
Background:
- Chronic kidney disease (CKD) is a significant comorbidity in human immunodeficiency virus (HIV) infection.
- Historically, HIV-associated nephropathy was the primary cause of CKD, particularly in individuals of African ancestry.
- Recent trends suggest a potential shift in CKD etiology among HIV-infected populations.
Purpose of the Study:
- To investigate the association between ethnicity and CKD risk in HIV-infected patients in the Netherlands.
- To determine if ethnic background influences the prevalence and incidence of CKD in contemporary HIV care.
Main Methods:
- Analysis of 16,836 patients from the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort.
- CKD defined as glomerular filtration rate <60 mL/min/1.73 m(2).
- Examined associations between ethnicity (Sub-Saharan African origin vs. Western European/Australasian origin) and prevalent/incident CKD.
Main Results:
- The prevalence of CKD at baseline was 2.7%.
- Sub-Saharan African origin was associated with a higher prevalence of baseline CKD (aOR 1.49).
- During follow-up, the risk of incident CKD was similar between patients of Sub-Saharan African origin and those of Western European/Australasian origin (aHR 1.00).
Conclusions:
- In the Netherlands, HIV-infected individuals of Sub-Saharan African origin had a higher prevalence of CKD at baseline.
- Ethnicity did not influence the development of new CKD over time in this cohort.
- Findings suggest a potential shift in CKD causes, moving away from HIV-associated nephropathy towards other etiologies.
Background:
Chronic kidney disease (CKD) is an important comorbidity during human immunodeficiency virus (HIV) infection. Historically, HIV-associated nephropathy has been the predominant cause of CKD and has primarily been observed in people of African ancestry. This study aims to investigate the role of ethnicity in relation to CKD risk in recent years.
Methods:
Analyses were performed including 16 836 patients from the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort. Baseline was defined as the first available creatinine level measurement after 1 January 2007; CKD was defined as a glomerular filtration rate of <60 mL/min/1.73 m(2). The associations between ethnicity and both prevalent CKD at baseline and incident CKD during follow-up were analyzed.
Results:
The prevalence of baseline CKD was 2.7% (460 of 16 836 patients). Birth in a sub-Saharan African country (hereafter, "SSA origin") was significantly associated with baseline CKD (adjusted odds ratio 1.49; 95% confidence interval [CI], 1.04-2.13). During follow-up (median duration, 4.7 years; interquartile range, 2.4-5.2), the rate of incident CKD was 6.0 events per 1000 person-years. The risk of newly developing CKD was similar between patients of SSA origin and those born in Western Europe, Australia, or New Zealand (adjusted hazard ratio, 1.00; 95% CI, .63-1.59).
Conclusions:
Among HIV-infected patients in the Netherlands, being of SSA origin was associated with a higher baseline CKD prevalence but had no impact on newly developing CKD over time. This suggests a shift in the etiology of CKD from HIV-associated nephropathy toward other etiologies.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

